Intravascular ultrasound and drug-eluting stents. Where are we now?

Minerva Cardioangiologica

Volumn 58, Issue 1, 2010, Pages 61-78

  Alfonso, F ^a   Dutary, J ^a   Rodriguez, V ^a   Zakhem, B ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Coronary restenosis; Stents; Thrombosis

Indexed keywords

ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CORONARY ARTERY ANEURYSM; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; REVIEW; STENT THROMBOSIS; TREATMENT FAILURE;

CORONARY ANEURYSM; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; PROSTHESIS FAILURE; PROSTHESIS IMPLANTATION; THROMBOSIS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77952395906     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC et al. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. (Pubitemid 46376800)
2. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with baremetal stents. N Engl J Med 2007;356:989-997 (Pubitemid 46376799)
3. Marroquin OC, Selzer F, Mulukutla SR, Williams DO. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008;358:342-352 (Pubitemid 351159233)
4. Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M et al. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959 (Pubitemid 40342825)
5. Alfonso F. The vulnerable stent. Why so dreadful? J Am Coll Cardiol 2008;51:2403-2406
6. de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E et al. Drug-eluting stent thrombosis. Results from the multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivo). J Am Coll Cardiol 2008;51:986-990 (Pubitemid 351318135)
7. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol 2007;49:839-848 (Pubitemid 46275353)
8. Alfonso F. Intravascular ultrasound analysis of lesion severity. From anatomy to physiology. In: Alfonso F, Botas J, editors. Intracoronary diagnostic techniques. Milan: McGraw Hill; 2003. p. 149-171
9. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 1998;19:1214-1223
10. Mudra H, di Mario C, de Jaegere P, Figulla HR, Macaya C, Zahn R et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 2001;104:1343-1349 (Pubitemid 32880145)
11. Gerber RT, Latib A, Ielasi A, Cosgrave J, Qasim A, Airoldi F et al. Defining new standard for IVUS optimized drug eluting stent implantation. The PRAVIO study. Catheter Cardiovasc Interv 2009;74:348-356
12. Gerber R, Colombo A. Does IVUS guidance of coronary interventions affect outcome? A prime example of the failure of randomized clinical trials. Catheter Cardiovasc Interv 2008;71:646-654 (Pubitemid 351550404)
13. Mintz.GS. Features and parameters of drug eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 2007;100:26M-35M.
14. Mintz GS, Weissman NJ. Intravascular ultrasound in the drug eluting stent era. J Am Coll Cardiol 2006;48:421-429 (Pubitemid 44093940)
15. Biondi-Zoccai GG, Chieffo A, Agostini P, Colombo A. Applying intravascular ultraosund to optimize the placement of coronary drug-eluting stents. Minerva Cardioangiol 2005;53:165-177 (Pubitemid 43942537)
16. Roy P, Waksman R. Intravascular ultrasound guidance in drug-eluting stent deployment. Minerva Cardioangiol 2008;56:67-77. (Pubitemid 351518493)
17. Alfonso F, Suarez A, Pérez L, Sabate M, Moreno R, Bañuelos C. Intravascular ultrasound in patients with challenging in-stent restenosis: importance of precise stent visualization. J Interv Cardiol 2006;19:153-159
18. Garcia-Garcia HM, Gonzalo N, Kukreja N, Alfonso F. Greyscale intravascular ultrasound and IVUS-radiofrequency tissue characterisation to improve understanding of the mechanisms of coronary stent thrombosis in drug-eluting stents. Eurointervention 2008;4(Suppl C):C33-8.
19. Ramcharitar S, Gonzalo N, van Geuns RJ, Garcia-Garcia HM, Wykrzykowska JJ, Ligthart JM et al. First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era? Nat Rev Cardiol 2009;6:374-378
20. Kim SW, Mintz GS, Hong YJ, Pakala R, Park KS, Pichard AD et al. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 2008;102:1182-1186
21. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
22. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 2004;43:1959-1963 (Pubitemid 38686788)
23. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus eluting stent implantation. Eur Heart J 2006;27:1305-1310
24. Kaneda H, Ako J, Honda Y, Terashima M, Morino Y, Yock PG et al. Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation. Am J Cardiol 2005;96:1404-1407 (Pubitemid 41566622)
25. Kaneda H, Koizumi T, Ako J, Terashima M, Morino Y, Honda Y et al. Impact of intravascular ultrasound lesions characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation. Am J Cardiolo 2005;96:1237-1241 (Pubitemid 41505400)
26. Alfonso F. Residual plaque burden after stenting: does it matter? Am J Cardiol 2002;90:910.
27. Alfonso F, García P, Pimentel G, Hernández R, Sabaté M, Escaned J et al. Predictors and implications of residual plaque burden after coronary stenting: an intravascular ultrasound study. Am Heart J 2003;145:254-261 (Pubitemid 36207946)
28. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS IV trial. J Am Coll Cardiol 2005;45:1201-1205 (Pubitemid 40523137)
29. Escolar E, Mintz GS, Popma J, Michalek A, Kim SW, Mandinov L et al. Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy(from TAXUS IV, V and VI). Am J Cardiol 2007;100:621-626
30. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899-907. (Pubitemid 351384734)
31. Javaid A, Chu WW, Cheneau E, Clavijo LC, Satler LF, Kent KM et al. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures. Cardiovasc Revasc Med 2006;7:208-211 (Pubitemid 44895019)
32. Jakabcin J, Spacek R, Bystron M, et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents with or without the IVUS guidance. Randomized control trial HOME DES IVUS. Cath Cardiovasc Interv 2009; Aug 7. [Epub ahead of print].
33. Alfonso F. Left main coronary artery stenting: crossing the Rubicon. J Am Coll Cardiol 2009;53:1769-1772
34. de la Torre Hernández JM, Ruiz-Lera M, Fernández-Friera L, Ruisanchez C, Sainz-Laso F, Zueco J et al. Prospective use of an Intravascular Ultrasound derived Minimum Lumen Area Cut-off Value in the assessment of intermediate left main coronary artery lesions. Rev Esp Cardiol 2007;60:811-818
35. Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J et al. for the Main Compare investigators. Impact of interventional ultrasound guidance on long term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2009;2:167-177
36. Alfonso F, Dutary J, Zakhem B. Letter by Alfonso et al regarding article, "impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis". Circ Cardiovasc Interv 2009;2:e3 (author reply E4).
37. Angiolillo DJ, Sabaté M, Alfonso F, Macaya C. "Candy wrapper" effect after drug-eluting stent implantation: déjà vu or stumbling over the same stone again?. Catheter Cardiovasc Interv 2004;61:387-391
38. Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M et al. Predictors of edge stenosos following sirolimus-eluting stent deployment: a quantitative intravascular ultrasound analysis of the SIRIUS trial. Am J Cardiol 1005;96:1251-1253
39. Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Costa MA, Alfonso F, Gómez-Hospital JA et al. Vascular effects of sirolimus vesus bare-metal stents in diabetic patients. Three-dimensional ultrasound results of the of the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. J Am Coll Cardiol 2006;47:2172-2179
40. Jensen LO, Maeng M, Mintz GS, Christiansen EH, Hansen KN, Galloe A et al. Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus. Am J Cardiol 2009;103;1083-1088
41. Alfonso F, Hernandez R, Goicolea J, Segovia J, Perez-Vizcayno MJ, Bañuelos C et al. Coronary stenting for acute coronary dissection after coronary angioplasty: implications of the residual dissection. J Am Coll Cardiol 1994;24:789-795
42. Nishida T, Colombo A, Briguori C, Stankovic G, Albiero R, Corvaja N et al. Outcome of non-obstructive residual dissections detected by intravascular ultrasound following percutaneous coronary interventions. Am J Cardiol 202;89:1257-1262
43. Liu X, Tsujita K, Maehara A, Mintz GS, Weisz G, Dangas GD et al. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug eluting stent implantation. JACC: Cardiovascular Interventions 2009;2:997-1004.
44. Biondi-Zoccai GG, Agostoni P, Sangiorgi GM, Airoldi F, Cosgrave J, Chieffo A et al. Incidence, predictors and outcomes of coronary dissections left untreated after drug eluting stent implantation. Eur Heart J 2006 27:540-546
45. Alfonso F. Residual coronary dissections after drug eluting stenting: the good, the bad, and the ugly. Eur Heart J, 2006; 27:503-505.
46. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K et al. Coronary restenosis after sirolimus-eluting stent implantation. Morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003;108:257-260
47. Maehara A, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B et al. Volumetric intravascular ultrasound analysis of paclitaxel-eluting and bare-metal stents in acute myocardial infarction. The harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy. Circulation 2009;120;1875-1882.
48. Kim SW, Mintz GS, Ohlmann P, Hassani SE, Fernandez S, Lu L et al. Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol 2006;98:1206-1211
49. Futamatsu H, Sabaté M, Angiolillo DJ, Jimenez-Quevedo P, Corros C, Morikawa-Futamatsu K et al. Characterization of plaque prolapse after drug-eluting stenteh implantation in diabetic patients. A three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol 2006;48:1139-1145 (Pubitemid 44345135)
50. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W et al. Frequency of stent fracture as a cause of coronary stenosis after sirolimus-eluting stent implantation. Am J Cardiol 2007;100:627-630 (Pubitemid 47223137)
51. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C et al. Classification and Potential Mechanisms of Intravascular Ultrasound Patterns of Stent Fracture. Am J Cardiol 2009;103:818-823
52. Opolski MP, Pracon R, Mintz GS, Okabe T, Pregowski J, Lee SY et al. Relation of Drug-eluting stent strut distribution to stent thrombosis in coronary arteries. Am J Cardiol 2009;104:343-348
53. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 2003;108:2747-2750 (Pubitemid 37498975)
54. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W et al.; TAXUS II Study Group. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents. Insights from the randomized TAXUS II trial. Circulation 2005;111:900-905
55. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG et al. Late incomplete stent apposition after sirolimus eluting stent implantation: a serial intravascular ultraound analysis. J Am Coll Cardiol 2005;46:1002-1005 (Pubitemid 41316506)
56. Kim YS, Koo BK, Seo JB, Park KW, Suh JW, Lee HY et al. The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation. Cath Cardiovasc Interv 2009;74:58-63.
57. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-419
58. Siqueira DA, Abizaid AA, Costa Jde R, Feres F, Mattos LA, Staico R et al. Late incomplete apposition after drug-eluting stent: incidence and potential for adverse clinical outcomes. Eur Heart J 2007;28:1304-1409
59. van der Hoeven BL, Liem SS, Dijkstra J, Bergheanu SC, Putter H, Antoni ML et al. Stent malapposition after sirolimus-eluting stent and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9.month intravascular ultrasound results of the MISSION! Intervention study. JACC Cardiovasc Interv 2008;1:192-201.
60. Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 2009 [Epub ahead of print].
61. Alfonso F, Cruz A, Garcia J. Late stent malapposition: innocent phenomenon or major risk marker? Eur Heart J 2010;31:260.
62. De la Torre Hernandez JM. Late acquired incomplete stent apposition: incidence, mechanism and clinical implications. Eurointervention 2009;5(Suppl D):D112-20.
63. Aleong G, Banelos C, Alfonso F. Intravascular ultrasound guidance of multiple drug eluting stent implantation in lesions associated with coronary aneurysms. J Invasive Cardiol 2009;21:E 77-80.
64. Alfonso F, Suárez A, Angiolillo DJ, Sabaté M, Escaned J, Moreno R et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004;90:1455-1459 (Pubitemid 39626325)
65. Alfonso F, Suárez A, Pérez-Vizcayno MJ, Moreno R, Escaned J, Bañuelos C et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007;50:2095-2097 (Pubitemid 350087569)
66. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434
67. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug eluting stent thrombosis. Circulation 2009;120:391-399
68. Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 2008;1:14-21.
69. Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R et al. Coronary aneurysms after drug eluting stent implantation: clinical, angiographic and intravascular ultrasound findings. J Am Coll Cardiol 2009;53:2053-2060
70. Alfonso F, Moreno R, Vergas J. Mycotic aneurysms after sirolimus-eluting coronary stenting. Catheter Cardiovasc Interv 2006;67:327-328
71. Alfonso F, Moreno R, Vergas J. Fatal infection after rapamycin eluting coronary stent implantation. Heart 2005;91:e51.
72. Alfonso F, Perez-Vizcayno MJ, Cruz A, Garcia J, Jimenez-Quevedo P, Escaned J, Hernandez R. Treatment of patients with in-stent restenosis. Eurointervention 2009;Suppl D:D70-8.
73. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, Bethencourt A, Martí V, López-Mínguez JR et al.; RIBS-II investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006;47:2152-2160
74. Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P et al. Angiographic patterns of drug eluting stents restenosis and one year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol 2008;102:311-315
75. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004;109:1085-1088
76. Alfonso F. Optimal implantation strategies using drug-eluting stents for in-stent restenosis: do we know the answer? Circulation 2004;110:e302.
77. Kalinczuk L, Demkow M, Mintz GS, Cedro K, Debski A, Ciszewski M et al. Impact of different restenting strategies on expansion of a drug eluting stent implanted to treat bare metal stent restenosis. Am J Cardiol 2009;104:531-537
78. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-998
79. Alfonso F. Pathophysiology of stent thrombosis: platelet activation, mechanical factors, or both?. J Am Coll Cardiol 2006;47:1086-1087
80. Alfonso F, Angiolillo DJ. Platelet function assessment to predict outcomes after coronary interventions: hype or hope? J Am Coll Cardiol 2006;48:1751-1754